Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Virgilio S, Alcaraz A, Pichon-Riviere A, Augustovski F, García Martí S, Bardach A, Ciapponi A. [Cannabinoids in patients with autism spectrum disorders] Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Documentos de Evaluación de Tecnologías Sanitarias, Informe de Respuesta Rapida No 523. 2017 Authors' conclusions No available scientific evidence which would allow determining the effectiveness of cannabinoids use for the treatment of patients with autism spectrum disorders was found. The clinical practice guidelines consulted do not mention the use of this technology in autism spectrum disorders and no coverage policies considering its use were found. Final publication URL www.iecs.org.ar Indexing Status Subject indexing assigned by CRD MeSH Analgesics; Autism Spectrum Disorder; Autistic Disorder; Cannabinoids; Humans Language Published Spanish Country of organisation Argentina English summary There is no English language summary available. Address for correspondence Institute for Clinical Effectiveness and Health Policy, Viamonte 2146 - 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina Tel: +54 11 49 66 00 82 Fax:+54 11 49 53 40 58 Email: info@iecs.org.ar AccessionNumber 32017000288 Date abstract record published 13/06/2017 |